The SURPASS program for type 2 diabetes showed tirzepatide produced larger A1C reductions and more weight loss than semaglutide, insulin glargine, or insulin degludec across multiple comparator trials
Please check with your individual insurance or FSA/HSA to ensure they will allow IM Nutrient Therapy before treatment as we do not allow refunds if they choose not to reimburse
For adults over 19, the recommended daily intake (RDI) is 2.4 micrograms (mcg)
The combination is most useful for patients with one or more of the following: BMI of 30 or higher , or BMI 27 with at least one weight-related condition such as type 2 diabetes, hypertension, or sleep apnea History of fatigue, low mood, or brain fog on previous diets or weight loss attempts Metformin use for type 2 diabetes or pre-diabetes (chronic metformin reduces B12) Long-term proton pump inhibitor use such as omeprazole, pantoprazole, or lansoprazole Vegetarian or vegan diet with limited animal protein intake Adults over 50 , where B12 absorption naturally declines Active strength training or higher physical demands while on a calorie deficit Patients who dont fit any of these profiles can still take semaglutide alone, then add B12 if symptoms suggest it

The authors reported that in obese mice, daily AOD-9604 administration over 14 days produced significant reductions in body weight gain, decreases in adipose tissue mass, and increases in fat oxidation, with effect sizes comparable to those of full-length human growth hormone [1]